Sunday
24 July 2005 |
Monday
25 July 2005 |
Tuesday
26 July 2005 |
Wednesday
27 July 2005 |
09:30 - 11:30
Satellite Symposium
Classic and modern ART 
Boehringer Ingelheim
[Sao Paulo session room]
09:30 - 14:00
Satellite Symposium
Grant opportunities and management workshop National Institute of Allergy and Infectious Diseases, NIH
NIH Satellite 1
[Manaus session room]
|
08:30 - 10:00
Plenary Session
Global Responses
[Sao Paulo session room]
Molecular epidemiology of HIV
Emerging HIV epidemics
Access to treatment prevention
|
08:30 - 10:00
Plenary Session
Prevention
[Sao Paulo session room]
Immune system prevention
Prevention host genetics
ART impact on prevention
|
08:30 - 10:00
Plenary Session
Treatment and treatment responses
[Sao Paulo session room]
ANRS/IAS - Prize
State of the art future directions of ART
HIV Paediatrics
Viral replication
|
| Break |
10:20 - 11:50
Oral Abstract Sessions
Dynamics of the HIV epidemic and measurement of incidence
[Rio de Janeiro session room]
ART scale up
[Sao Paulo session room]
Viral pathogenesis
[Brasilia session room]
Molecular epidemiology and transmission
[Manaus session room]
|
10:20 - 11:50
Oral Abstract Sessions
HIV vaccine development trials
[Rio de Janeiro session room]
Sexual transmission
[Sao Paulo session room]
Prevention of mother-to-child transmission worldwide
[Brasilia session room]
New antiretroviral agents
[Manaus session room]
|
10:20 - 11:50
Oral Abstract Sessions
Paediatric HIV disease: treatment and complications
[Rio de Janeiro session room]
Antiretroviral treatment strategies
[Sao Paulo session room]
Harm reduction
[Brasilia session room]
Host factor/virus interactions
[Manaus session room]
|
| Break |
12:00 - 14:00
Satellite Symposium
Viral entry inhibitors: revolutionizing the treatment of HIV?
IMP, supported by Pfizer
[Sao Paulo session room]
|
L
u
n
c
h |
|
12:00 - 14:00
Satellite Symposium
Paving the way for advances in HIV
GlaxoSmithKline
[Sao Paulo session room]
Care, treatment and support of children in low resource settings
UNICEF / WHO
[Brasilia session room]
12:30 - 13:30
Update
Tenofovir prophylactic research stakeholder meeting
IAS
[Manaus session room]
|
L
u
n
c
h |
|
12:00 - 14:00
Satellite Symposium
Managing metabolic issues and cardiovascular risk in HIV-infected patients: an interactive case-based symposium
Bristol-Myers Squibb
[Sao Paulo session room]
Female initiated methods of HIV prevention
The Bill & Melinda Gates Foundation
[Brasilia session room]
|
L
u
n
c
h |
|
12:00 - 14:00
Special Sessions
Updated applications of ART a special audience interactive session
IAS - USA
[Sao Paulo session room]
Operations research to support scale-up of HIV/AIDS programmes: what is the way forward?
IAS/Doris Duke Charitable Foundation
[Brasilia session room]
|
12:30 - 13:45
Poster Presentations
[Poster Area]
Microbicides
[Belem cubicle]
Scale up of antiretroviral therapy
[Recife cubicle]
Sexual transmission
[Natal cubicle]
Late breakers
[Salvador cubicle]
|
12:30 - 13:45
Poster Presentations
[Poster Area]
HIV-specific cellular immunity
[Belem cubicle]
HIV drug resistance around the world
[Recife cubicle]
Strategies to increase VCT uptake
[Natal cubicle]
Understanding prevention of mother-to-child transmission
[Salvador cubicle]
|
12:30 - 13:45
Poster Presentations
[Poster Area]
New antiretroviral targets and compounds, mechanisms of drug resistance
[Belem cubicle]
Tuberculosis and other opportunistic infections
[Recife cubicle]
Planning for vaccine efficacy trials
[Natal cubicle]
Therapeutic vaccination
[Salvador cubicle]
|
| Break |
14:15 - 16:15
Satellite Symposium
Critical issues for long-term management of HIV infection in resource-limited settings
NIH Satellite 2
[Brasilia session room]
|
14:10 - 15:40
Fora
What will it take to control the epidemic?
[Rio de Janeiro session room]
HIV/TB Co-Infection: new visions, new directions
[Sao Paulo session room]
Mechanisms of drug resistance and fitness
[Brasilia session room]
Innate immunity
[Manaus session room]
|
14:10 - 15:40
Fora
Complications of HIV therapy
[Rio de Janeiro session room]
PMTCT, toxicity and resistance
[Sao Paulo session room]
New challenges in HIV co-infections
[Brasilia session room]
Role of adaptive immunity and viral evolution in vaccine design
[Manaus session room]
|
14:10 - 15:40
Fora
Prevention in health care settings
[Rio de Janeiro session room]
Salvage therapy in different clinical settings
[Sao Paulo session room]
Lab monitoring in resource-limited settings
[Brasilia session room]
Viral replication and entry
[Manaus session room]
|
| Break |
16:30 - 18:30
Satellite Symposium
Individuality: an interactive case-study symposium exploring optimal treatments for individual patients
Roche
[Sao Paulo session room]
Grant opportunities and management workshop National Institute of Allergy and Infectious Diseases, NIH
NIH Satellite 1 (Part 2)
[Manaus session room]
19:30 - 21:00
Opening Ceremony
Opening Ceremony and Welcome Reception
[Sao Paulo session room]
21:00 - 22:00
Welcome Reception
[Pavilion 5]
|
16:00 - 17:30
Debates
Have we prematurely discarded triple NRTI regimens?
[Rio de Janeiro session room]
Clinical trials take precedent for vaccine development at the current time: yes or no?
[Sao Paulo session room]
How can ART observational cohorts and randomized clinical trials inform policy and practice
[Brasilia session room]
Is there an immune correlate to live attenuated vaccine protection?
[Manaus session room]
|
16:00 - 17:30
Debates
Compared to what: what is the future of HIV prevention efficacy trials?
[Rio de Janeiro session room]
ART and other medical care in the context of prevention trials: who is responsible?
[Brasilia session room]
Can HAART completely block HIV replication?
[Manaus session room]
16:00 - 17:30
Special Forum
Brand drugs and generic drugs: from antagonism to synergy?
[Sao Paulo session room]
|
16:00 - 16:30
Oral Abstract Sessions
Late breakers
[Sao Paulo session room]
Late breakers 2
[Brasilia session room]
16:30 - 17:00
Special Lecture
The status of the response: what will it take to turn the epidemic around?
[Sao Paulo session room]
17:00 - 18:00
Rapporteur Summaries and Closing Ceremony
Summaries and Closing
[Sao Paulo session room]
|
| Break | |
18:00 - 20:00
Satellite Symposium
HIV drug resistance in the context of ART scale-up: WHO global strategy and practical applications
WHO/UNITE/MORE
[Brasilia session room]
Women, sexual violence and HIV risk
The American Foundation for AIDS Research (amfAR)
[Manaus session room]
The Global HIV/AIDS Vaccine Enterprise
The Global HIV/AIDS Vaccine Enterprise
[Press Conference Room 1]
|
18:00 - 20:00
Satellite Symposium
Scientific and ethical challenges of conducting pre-exposure prophylactic research in resource-poor countries
IAS Industry Liaison Forum
[Sao Paulo session room]
WHO public health approach to decentralized HIV care, ART and prevention: strategy, tools and country experience
WHO
[Manaus session room] |
|